Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Site, combined hepatocellular carcinoma and cholangiocarcinoma, liver disorder, neoplasm	Recruiting	Not stated	2025-02-27		NCT06849180

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Eastern Hepatobiliary Surgery Hospital	22
Jiangsu Cancer Institute & Hospital	45
Shanghai Zhongshan Hospital	347
Sun Yat-Sen University Cancer Center	74
The First Affiliated Hospital of Zhengzhou University	203
Yunnan Cancer Hospital	46
Zhejiang Cancer Hospital	142
Zhongda Hospital	46

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Zhongda Hospital	Nanjing	China	5